Cancer Vaccines
Research from University of Notre Dame in cancer vaccines provides new insights
Published in Vaccine Weekly, May 16th, 2007
A new study, "Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund-Wistar rats," is now available. According to recent research from the United States, "Reducing expression of the tissue factor gene in prostate adenocarcinoma cells (PAIII) results in a cell line that, in vivo, mimics the growth of wildtype (wt) PAIII. However, instead of continuing to grow and metastasize as wt PAIII tumors do, tissue factor deficient PAIII (TFD PAIII) masses spontaneously regress after several weeks."
"Although whole cell vaccines are typically inactivated prior to administration to prevent proliferation within the host, numerous studies have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-05-16)
More Articles from Vaccine Weekly
- Sickle Cell Anemia
Serious illness among children with sickle cell disease reduced with vaccine - Autism
NAA and SafeMinds Call for Increased Environmental Research on Autism at IOM Workshop - Bird Flu
CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals - Bird Flu
LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic Protection Against Influenza Challenge With Virus-Like Particle Immunization - Bird Flu
Purdue Research Foundation Licenses New Flu Vaccine Candidate to PaxVax - Cancer Vaccines
Advaxis Announces Completion of Patient Accrual in Lovaxin C Phase I/II Trial - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
